Financials
- Market Capitalization 2.05 B
- Employee 540
- Founded 2008
- CEO N/A
- Website www.agios.com
- Headquarter Delaware, United States
- FIGI BBG000QY4ZD0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.82
Fiyat/satışlar oranı
29.21
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1984 | STOK Stoke Therapeutics, Inc. - Common Stock | 32.59 USD | -1.51% | +2.61% | +10.74% | +62.95% | 2.10 B USD | ||
| 1999 | ZYME Zymeworks Inc. - Common Stock | 29.01 USD | -1.02% | +7.44% | +28.02% | +63.53% | 2.06 B USD | ||
| 2040 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.96 USD | -1.00% | -3.56% | +10.17% | +109.86% | 1.94 B USD | ||
| 2049 | VIR Vir Biotechnology, Inc. - Common Stock | 11.31 USD | +2.08% | +21.48% | +27.94% | +89.13% | 1.91 B USD |